Cargando…
Serum GP73 predicts posthepatectomy outcomes in patients with hepatocellular carcinoma
BACKGROUND AND AIMS: Serum GP73 is a useful biomarker in assessing hepatic fibrosis degree. The aim of this study was to evaluate the predictive value of serum GP73 level for posthepatectomy short-term outcomes in hepatocellular carcinoma (HCC) patients. METHODS: A total of 280 patients undergoing l...
Autores principales: | Ke, Meng-yun, Wu, Xiao-ning, Zhang, Yao, Wang, Saisai, Lv, Yi, Dong, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498666/ https://www.ncbi.nlm.nih.gov/pubmed/31046807 http://dx.doi.org/10.1186/s12967-019-1889-0 |
Ejemplares similares
-
Serum Irisin Predicts Posthepatectomy Complications in Patients with Hepatocellular Carcinoma
por: Zhang, Jia, et al.
Publicado: (2019) -
A novel model for predicting posthepatectomy liver failure in patients with hepatocellular carcinoma
por: Peng, Wei, et al.
Publicado: (2019) -
Spleen stiffness and volume help to predict posthepatectomy liver failure in patients with hepatocellular carcinoma
por: Peng, Wei, et al.
Publicado: (2019) -
Serum GP73 is complementary to AFP and GGT-II for the diagnosis of hepatocellular carcinoma
por: HOU, SI-CONG, et al.
Publicado: (2013) -
GP73-mediated secretion of AFP and GP73 promotes proliferation and metastasis of hepatocellular carcinoma cells
por: Liu, Yujuan, et al.
Publicado: (2021)